Global Live Cell Encapsulation Market By Polymeric Indication (Cellulose, Alginate, Chitosan, Others); By Application ( Drug Delivery, Research, Regenerative Medicines, Cell transplantation, Others); By Disease Indication(Cancer, Diabetes and Others)By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia(Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia) Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029

Report ID :AMI-1074 | Category : Healthcare | Published Date : February, 2022 | Pages : 402 | Format :PDF

Industry Trends

Cell encapsulation is a technique of entrapping a cell into selectively permeable membrane, thereby making them potential treatment tool for various diseases like cancer, diabetes, lysosomal storage diseases, etc. Global live cell encapsulation market is projected to be driven by the increasing prevalence of target diseases. According to WHO, about 422 million people suffer from diabetes worldwide and 1.5 million deaths are directly attributed to diabetes each year. Type 1 diabetes mellitus (T1DM) is an increasing health hazard. Therefore, Islet encapsulation technologies involving nano, micro, macro-encapsulation, and bioprinting represent promising approaches for T1DM treatment. Also, the prevalence of lysosomal disorders such as gaucher’s disease in European countries and rising rate of cancer patients across the globe has raised the demand for specific treatments. Moreover, with continuous advancement in pharmaceutical technologies, the live cell encapsulation market is likely to witness lucrative growth. For instance, an inverse-breathing encapsulation system for cell delivery to treat hormone-deficient diseases and endocrine disorders will be a promising approach. Also, the increasing research programs to establish the clinical efficacy of cell encapsulation is adding fuel to the market growth. Rising investment from public and private sectors for the development of products is another factors leading for the market to propel in the future years. For instance, Eli Lilly invested up to USD473 million in Sigilon Therapeutics and the cell encapsulation technology to develop a potential treatment for type 1 diabetes.

In terms of revenue, the global live cell encapsulation market was valued at US$ 285 Mn in 2020 growing at a CAGR of 3.2% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.

Global Live Cell Encapsulation Market Revenue & Forecast, (US$ Million), 2015 – 2029

Polymeric Material Outlook

Based on polymeric material, the live cell encapsulation market has been segmented into cellulose, alginate, chitosan and others. The alginate segment dominates the live cell encapsulation market owing to its high permeability, high mechanical strength and uniform cell structure. Also, it provides biocompatibility, biodegradability, and nontoxicity which makes it efficient for drug delivery or protein delivery system. For the drugs which require greater protection with preferential absorption in the intestinal tract or other conditions such as modified drug release, alginate is a preferable polymer.

Application Outlook:

Based on the application, the live cell encapsulation market has been segmented into drug delivery, research, regenerative medicine, cell transplantation and others. Among these, the drug delivery segment dominates the live cell encapsulation market. The growth of the segment is attributed to the adoption of cell encapsulation for drug delivery owing to its benefits such as reduced toxicity, improved efficacy, etc. Moreover, it provides controlled release of drugs. Microencapsulation holds promise for the treatment of many diseases by the continuous delivery of therapeutic products, thereby impelling the segment growth.

Disease Indication Outlook:

Based on disease indication, the global live cell encapsulation market has been segmented into cancer, diabetes and others. Cancer segment dominates the market owing to rising prevalence of cancer cases across the globe. Cancer is the leading cause of death globally which has raised the demand for various therapies to treat it. Various market players are focusing on the development of therapies to treat cancer. For instance. PharmaCyte Biotech, a clinical stage biotechnology company is developing targeted treatments for cancer using live-cell encapsulation technique. Also, nano-medicine is a rapidly developing area that is revolutionizing cancer diagnosis and therapy. Additionally, increasing investments in research and development is fuelling the market growth. For instance, Nuvilex has invested around USD 25-million in two independent Phase II clinical trials in patients with advanced, inoperable pancreatic cancer using the combination of the widely used anti-cancer drug, ifosfamide, together with encapsulated cells capable of converting the ifosfamide into its "cancer-killing" form.

Region Outlook:

North American region registered for the largest regional market in 2020 in the live cell encapsulation market. The market growth is attributed to the presence of key players, increasing per capita healthcare expenditure, increasing funding and investment for research and development programs in the United States and Canada. Established healthcare infrastructure is another key factor, which is accountable for its large share in the market.

Competitive Landscape

The report provides both, qualitative and quantitative research of the global live cell encapsulation market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings, and specification amongst others.

Some of the key players operating in the global live cell encapsulation market are:

Austrianova
Blacktrace Holdings Ltd.
Büchi Labortechnik AG
Defymed
Evonik Industries
Gloriana Therapeutics
Merck KGaA
PharmaCyte Biotech Inc.
Sigilon Therapeutics, Inc.
Other Market Participants

Global Live Cell Encapsulation Market:

By Polymeric Material

Cellulose
Alginate
Chitosan
Others

By Application

Drug Delivery
Research
Regenerative Medicine
Cell Transplantation
Others

By Disease Indication

Cancer
Diabetes
Others

By Region

North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
  - Denmark
  - Finland
  - Iceland
  - Sweden
  - Norway
- Benelux Union
  - Belgium
  - The Netherlands
  - Luxembourg
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
  - Indonesia
  - Thailand
  - Malaysia
  - Singapore
  - Rest of Southeast Asia
- Rest of Asia Pacific
Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America

Table of Contents

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2019

1.2.2. Base Year: 2020

1.2.3. Forecast Years: 2021 – 2029

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from AMI’s Perspective**

5. Holistic Overview of Live Cell Encapsulation Market

6. Market Synopsis: Live Cell Encapsulation Market

7. Live Cell Encapsulation Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.2.4. Challenges

7.3. Trends in Live Cell Encapsulation Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Live Cell Encapsulation Market

7.6. Porter’s Five Force Analysis

7.7. Impact of Covid-19 on Live Cell Encapsulation Market

8. Global Live Cell Encapsulation Market Analysis and Forecasts, 2021 – 2029

8.1. Overview

8.1.1. Global Live Cell Encapsulation Market Revenue (US$ Mn)

8.2. Global Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

8.2.1. Cellulose

8.2.1.1. Definition

8.2.1.2. Market Estimation and Penetration, 2015 - 2020

8.2.1.3. Market Forecast, 2021 - 2029

8.2.1.4. Compound Annual Growth Rate (CAGR)

8.2.1.5. Regional Bifurcation

8.2.1.5.1. North America

8.2.1.5.1.1. Market Estimation, 2015 - 2020

8.2.1.5.1.2. Market Forecast, 2021 - 2029

8.2.1.5.2. Europe

8.2.1.5.2.1. Market Estimation, 2015 - 2020

8.2.1.5.2.2. Market Forecast, 2021 - 2029

8.2.1.5.3. Asia Pacific

8.2.1.5.3.1. Market Estimation, 2015 - 2020

8.2.1.5.3.2. Market Forecast, 2021 - 2029

8.2.1.5.4. Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2015 - 2020

8.2.1.5.4.2. Market Forecast, 2021 - 2029

8.2.1.5.5. Latin America

8.2.1.5.5.1. Market Estimation, 2015 - 2020

8.2.1.5.5.2. Market Forecast, 2021 - 2029

8.2.2. Alginate

8.2.2.1. Definition

8.2.2.2. Market Estimation and Penetration, 2015 - 2020

8.2.2.3. Market Forecast, 2021 - 2029

8.2.2.4. Compound Annual Growth Rate (CAGR)

8.2.2.5. Regional Bifurcation

8.2.2.5.1. North America

8.2.2.5.1.1. Market Estimation, 2015 - 2020

8.2.2.5.1.2. Market Forecast, 2021 - 2029

8.2.2.5.2. Europe

8.2.2.5.2.1. Market Estimation, 2015 - 2020

8.2.2.5.2.2. Market Forecast, 2021 - 2029

8.2.2.5.3. Asia Pacific

8.2.2.5.3.1. Market Estimation, 2015 - 2020

8.2.2.5.3.2. Market Forecast, 2021 - 2029

8.2.2.5.4. Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2015 - 2020

8.2.2.5.4.2. Market Forecast, 2021 - 2029

8.2.2.5.5. Latin America

8.2.2.5.5.1. Market Estimation, 2015 - 2020

8.2.2.5.5.2. Market Forecast, 2021 - 2029

8.2.3. Chitosan

8.2.3.1. Definition

8.2.3.2. Market Estimation and Penetration, 2015 - 2020

8.2.3.3. Market Forecast, 2021 - 2029

8.2.3.4. Compound Annual Growth Rate (CAGR)

8.2.3.5. Regional Bifurcation

8.2.3.5.1. North America

8.2.3.5.1.1. Market Estimation, 2015 - 2020

8.2.3.5.1.2. Market Forecast, 2021 - 2029

8.2.3.5.2. Europe

8.2.3.5.2.1. Market Estimation, 2015 - 2020

8.2.3.5.2.2. Market Forecast, 2021 - 2029

8.2.3.5.3. Asia Pacific

8.2.3.5.3.1. Market Estimation, 2015 - 2020

8.2.3.5.3.2. Market Forecast, 2021 - 2029

8.2.3.5.4. Middle East and Africa

8.2.3.5.4.1. Market Estimation, 2015 - 2020

8.2.3.5.4.2. Market Forecast, 2021 - 2029

8.2.3.5.5. Latin America

8.2.3.5.5.1. Market Estimation, 2015 - 2020

8.2.3.5.5.2. Market Forecast, 2021 - 2029

8.2.4. Others

8.2.4.1. Definition

8.2.4.2. Market Estimation and Penetration, 2015 - 2020

8.2.4.3. Market Forecast, 2021 - 2029

8.2.4.4. Compound Annual Growth Rate (CAGR)

8.2.4.5. Regional Bifurcation

8.2.4.5.1. North America

8.2.4.5.1.1. Market Estimation, 2015 - 2020

8.2.4.5.1.2. Market Forecast, 2021 - 2029

8.2.4.5.2. Europe

8.2.4.5.2.1. Market Estimation, 2015 - 2020

8.2.4.5.2.2. Market Forecast, 2021 - 2029

8.2.4.5.3. Asia Pacific

8.2.4.5.3.1. Market Estimation, 2015 - 2020

8.2.4.5.3.2. Market Forecast, 2021 - 2029

8.2.4.5.4. Middle East and Africa

8.2.4.5.4.1. Market Estimation, 2015 - 2020

8.2.4.5.4.2. Market Forecast, 2021 - 2029

8.2.4.5.5. Latin America

8.2.4.5.5.1. Market Estimation, 2015 - 2020

8.2.4.5.5.2. Market Forecast, 2021 - 2029

8.3. Key Segment for Channeling Investments

8.3.1. By Polymeric Material

9. Global Live Cell Encapsulation Market Analysis and Forecasts, 2021 – 2029

9.1. Overview

9.2. Global Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

9.2.1. Drug Delivery

9.2.1.1. Definition

9.2.1.2. Market Estimation and Penetration, 2015 - 2020

9.2.1.3. Market Forecast, 2021 - 2029

9.2.1.4. Compound Annual Growth Rate (CAGR)

9.2.1.5. Regional Bifurcation

9.2.1.5.1. North America

9.2.1.5.1.1. Market Estimation, 2015 - 2020

9.2.1.5.1.2. Market Forecast, 2021 - 2029

9.2.1.5.2. Europe

9.2.1.5.2.1. Market Estimation, 2015 - 2020

9.2.1.5.2.2. Market Forecast, 2021 - 2029

9.2.1.5.3. Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 - 2020

9.2.1.5.3.2. Market Forecast, 2021 - 2029

9.2.1.5.4. Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 - 2020

9.2.1.5.4.2. Market Forecast, 2021 - 2029

9.2.1.5.5. Latin America

9.2.1.5.5.1. Market Estimation, 2015 - 2020

9.2.1.5.5.2. Market Forecast, 2021 - 2029

9.2.2. Research

9.2.2.1. Definition

9.2.2.2. Market Estimation and Penetration, 2015 - 2020

9.2.2.3. Market Forecast, 2021 - 2029

9.2.2.4. Compound Annual Growth Rate (CAGR)

9.2.2.5. Regional Bifurcation

9.2.2.5.1. North America

9.2.2.5.1.1. Market Estimation, 2015 - 2020

9.2.2.5.1.2. Market Forecast, 2021 - 2029

9.2.2.5.2. Europe

9.2.2.5.2.1. Market Estimation, 2015 - 2020

9.2.2.5.2.2. Market Forecast, 2021 - 2029

9.2.2.5.3. Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 - 2020

9.2.2.5.3.2. Market Forecast, 2021 - 2029

9.2.2.5.4. Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 - 2020

9.2.2.5.4.2. Market Forecast, 2021 - 2029

9.2.2.5.5. Latin America

9.2.2.5.5.1. Market Estimation, 2015 - 2020

9.2.2.5.5.2. Market Forecast, 2021 - 2029

9.2.3. Regenerative Medicine

9.2.3.1. Definition

9.2.3.2. Market Estimation and Penetration, 2015 - 2020

9.2.3.3. Market Forecast, 2021 - 2029

9.2.3.4. Compound Annual Growth Rate (CAGR)

9.2.3.5. Regional Bifurcation

9.2.3.5.1. North America

9.2.3.5.1.1. Market Estimation, 2015 - 2020

9.2.3.5.1.2. Market Forecast, 2021 - 2029

9.2.3.5.2. Europe

9.2.3.5.2.1. Market Estimation, 2015 - 2020

9.2.3.5.2.2. Market Forecast, 2021 - 2029

9.2.3.5.3. Asia Pacific

9.2.3.5.3.1. Market Estimation, 2015 - 2020

9.2.3.5.3.2. Market Forecast, 2021 - 2029

9.2.3.5.4. Middle East and Africa

9.2.3.5.4.1. Market Estimation, 2015 - 2020

9.2.3.5.4.2. Market Forecast, 2021 - 2029

9.2.3.5.5. Latin America

9.2.3.5.5.1. Market Estimation, 2015 - 2020

9.2.3.5.5.2. Market Forecast, 2021 - 2029

9.2.4. Cell Transplantation

9.2.4.1. Definition

9.2.4.2. Market Estimation and Penetration, 2015 - 2020

9.2.4.3. Market Forecast, 2021 - 2029

9.2.4.4. Compound Annual Growth Rate (CAGR)

9.2.4.5. Regional Bifurcation

9.2.4.5.1. North America

9.2.4.5.1.1. Market Estimation, 2015 - 2020

9.2.4.5.1.2. Market Forecast, 2021 - 2029

9.2.4.5.2. Europe

9.2.4.5.2.1. Market Estimation, 2015 - 2020

9.2.4.5.2.2. Market Forecast, 2021 - 2029

9.2.4.5.3. Asia Pacific

9.2.4.5.3.1. Market Estimation, 2015 - 2020

9.2.4.5.3.2. Market Forecast, 2021 - 2029

9.2.4.5.4. Middle East and Africa

9.2.4.5.4.1. Market Estimation, 2015 - 2020

9.2.4.5.4.2. Market Forecast, 2021 - 2029

9.2.4.5.5. Latin America

9.2.4.5.5.1. Market Estimation, 2015 - 2020

9.2.4.5.5.2. Market Forecast, 2021 - 2029

9.2.5. Others

9.2.5.1. Definition

9.2.5.2. Market Estimation and Penetration, 2015 - 2020

9.2.5.3. Market Forecast, 2021 - 2029

9.2.5.4. Compound Annual Growth Rate (CAGR)

9.2.5.5. Regional Bifurcation

9.2.5.5.1. North America

9.2.5.5.1.1. Market Estimation, 2015 - 2020

9.2.5.5.1.2. Market Forecast, 2021 - 2029

9.2.5.5.2. Europe

9.2.5.5.2.1. Market Estimation, 2015 - 2020

9.2.5.5.2.2. Market Forecast, 2021 - 2029

9.2.5.5.3. Asia Pacific

9.2.5.5.3.1. Market Estimation, 2015 - 2020

9.2.5.5.3.2. Market Forecast, 2021 - 2029

9.2.5.5.4. Middle East and Africa

9.2.5.5.4.1. Market Estimation, 2015 - 2020

9.2.5.5.4.2. Market Forecast, 2021 - 2029

9.2.5.5.5. Latin America

9.2.5.5.5.1. Market Estimation, 2015 - 2020

9.2.5.5.5.2. Market Forecast, 2021 - 2029

9.3. Key Segment for Channeling Investments

9.3.1. By Application

10. Global Live Cell Encapsulation Market Analysis and Forecasts, 2021 – 2029

10.1. Overview

10.2. Global Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

10.2.1. Cancer

10.2.1.1. Definition

10.2.1.2. Market Estimation and Penetration, 2015 - 2020

10.2.1.3. Market Forecast, 2021 - 2029

10.2.1.4. Compound Annual Growth Rate (CAGR)

10.2.1.5. Regional Bifurcation

10.2.1.5.1. North America

10.2.1.5.1.1. Market Estimation, 2015 - 2020

10.2.1.5.1.2. Market Forecast, 2021 - 2029

10.2.1.5.2. Europe

10.2.1.5.2.1. Market Estimation, 2015 - 2020

10.2.1.5.2.2. Market Forecast, 2021 - 2029

10.2.1.5.3. Asia Pacific

10.2.1.5.3.1. Market Estimation, 2015 - 2020

10.2.1.5.3.2. Market Forecast, 2021 - 2029

10.2.1.5.4. Middle East and Africa

10.2.1.5.4.1. Market Estimation, 2015 - 2020

10.2.1.5.4.2. Market Forecast, 2021 - 2029

10.2.1.5.5. Latin America

10.2.1.5.5.1. Market Estimation, 2015 - 2020

10.2.1.5.5.2. Market Forecast, 2021 - 2029

10.2.2. Diabetes

10.2.2.1. Definition

10.2.2.2. Market Estimation and Penetration, 2015 - 2020

10.2.2.3. Market Forecast, 2021 - 2029

10.2.2.4. Compound Annual Growth Rate (CAGR)

10.2.2.5. Regional Bifurcation

10.2.2.5.1. North America

10.2.2.5.1.1. Market Estimation, 2015 - 2020

10.2.2.5.1.2. Market Forecast, 2021 - 2029

10.2.2.5.2. Europe

10.2.2.5.2.1. Market Estimation, 2015 - 2020

10.2.2.5.2.2. Market Forecast, 2021 - 2029

10.2.2.5.3. Asia Pacific

10.2.2.5.3.1. Market Estimation, 2015 - 2020

10.2.2.5.3.2. Market Forecast, 2021 - 2029

10.2.2.5.4. Middle East and Africa

10.2.2.5.4.1. Market Estimation, 2015 - 2020

10.2.2.5.4.2. Market Forecast, 2021 - 2029

10.2.2.5.5. Latin America

10.2.2.5.5.1. Market Estimation, 2015 - 2020

10.2.2.5.5.2. Market Forecast, 2021 - 2029

10.2.3. Others

10.2.3.1. Definition

10.2.3.2. Market Estimation and Penetration, 2015 - 2020

10.2.3.3. Market Forecast, 2021 - 2029

10.2.3.4. Compound Annual Growth Rate (CAGR)

10.2.3.5. Regional Bifurcation

10.2.3.5.1. North America

10.2.3.5.1.1. Market Estimation, 2015 - 2020

10.2.3.5.1.2. Market Forecast, 2021 - 2029

10.2.3.5.2. Europe

10.2.3.5.2.1. Market Estimation, 2015 - 2020

10.2.3.5.2.2. Market Forecast, 2021 - 2029

10.2.3.5.3. Asia Pacific

10.2.3.5.3.1. Market Estimation, 2015 - 2020

10.2.3.5.3.2. Market Forecast, 2021 - 2029

10.2.3.5.4. Middle East and Africa

10.2.3.5.4.1. Market Estimation, 2015 - 2020

10.2.3.5.4.2. Market Forecast, 2021 - 2029

10.2.3.5.5. Latin America

10.2.3.5.5.1. Market Estimation, 2015 - 2020

10.2.3.5.5.2. Market Forecast, 2021 - 2029

10.3. Key Segment for Channeling Investments

10.3.1. By Disease Indication

11. North America Live Cell Encapsulation Market Analysis and Forecasts, 2021 - 2029

11.1. Overview

11.1.1. North America Live Cell Encapsulation Market Revenue (US$ Mn)

11.2. North America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

11.2.1. Cellulose

11.2.2. Alginate

11.2.3. Chitosan

11.2.4. Others

11.3. North America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

11.3.1. Drug Delivery

11.3.2. Research

11.3.3. Regenerative Medicine

11.3.4. Cell Transplantation

11.3.5. Others

11.4. North America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

11.4.1. Cancer

11.4.2. Diabetes

11.4.3. Others

11.5. North America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Country

11.5.1. U.S

11.5.1.1. U.S Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

11.5.1.1.1. Cellulose

11.5.1.1.2. Alginate

11.5.1.1.3. Chitosan

11.5.1.1.4. Others

11.5.1.2. U.S Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

11.5.1.2.1. Drug Delivery

11.5.1.2.2. Research

11.5.1.2.3. Regenerative Medicine

11.5.1.2.4. Cell Transplantation

11.5.1.2.5. Others

11.5.1.3. U.S Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

11.5.1.3.1. Cancer

11.5.1.3.2. Diabetes

11.5.1.3.3. Others

11.5.2. Canada

11.5.2.1. Canada Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

11.5.2.1.1. Cellulose

11.5.2.1.2. Alginate

11.5.2.1.3. Chitosan

11.5.2.1.4. Others

11.5.2.2. Canada Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

11.5.2.2.1. Drug Delivery

11.5.2.2.2. Research

11.5.2.2.3. Regenerative Medicine

11.5.2.2.4. Cell Transplantation

11.5.2.2.5. Others

11.5.2.3. Canada Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

11.5.2.3.1. Cancer

11.5.2.3.2. Diabetes

11.5.2.3.3. Others

11.5.3. Mexico

11.5.3.1. Mexico Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

11.5.3.1.1. Cellulose

11.5.3.1.2. Alginate

11.5.3.1.3. Chitosan

11.5.3.1.4. Others

11.5.3.2. Mexico Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

11.5.3.2.1. Drug Delivery

11.5.3.2.2. Research

11.5.3.2.3. Regenerative Medicine

11.5.3.2.4. Cell Transplantation

11.5.3.2.5. Others

11.5.3.3. Mexico Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

11.5.3.3.1. Cancer

11.5.3.3.2. Diabetes

11.5.3.3.3. Others

11.5.4. Rest of North America

11.5.4.1. Rest of North America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

11.5.4.1.1. Cellulose

11.5.4.1.2. Alginate

11.5.4.1.3. Chitosan

11.5.4.1.4. Others

11.5.4.2. Rest of North America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

11.5.4.2.1. Drug Delivery

11.5.4.2.2. Research

11.5.4.2.3. Regenerative Medicine

11.5.4.2.4. Cell Transplantation

11.5.4.2.5. Others

11.5.4.3. Rest of North America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

11.5.4.3.1. Cancer

11.5.4.3.2. Diabetes

11.5.4.3.3. Others

11.6. Key Segment for Channeling Investments

11.6.1. By Country

11.6.2. By Polymeric Material

11.6.3. By Application

11.6.4. By Disease Indication

12. Europe Live Cell Encapsulation Market Analysis and Forecasts, 2021 - 2029

12.1. Overview

12.1.1. Europe Live Cell Encapsulation Market Revenue (US$ Mn)

12.2. Europe Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

12.2.1. Cellulose

12.2.2. Alginate

12.2.3. Chitosan

12.2.4. Others

12.3. Europe Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

12.3.1. Drug Delivery

12.3.2. Research

12.3.3. Regenerative Medicine

12.3.4. Cell Transplantation

12.3.5. Others

12.4. Europe Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

12.4.1. Cancer

12.4.2. Diabetes

12.4.3. Others

12.5. Europe Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Country

12.5.1. France

12.5.1.1. France Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

12.5.1.1.1. Cellulose

12.5.1.1.2. Alginate

12.5.1.1.3. Chitosan

12.5.1.1.4. Others

12.5.1.2. France Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

12.5.1.2.1. Drug Delivery

12.5.1.2.2. Research

12.5.1.2.3. Regenerative Medicine

12.5.1.2.4. Cell Transplantation

12.5.1.2.5. Others

12.5.1.3. France Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

12.5.1.3.1. Cancer

12.5.1.3.2. Diabetes

12.5.1.3.3. Others

12.5.2. The UK

12.5.2.1. The UK Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

12.5.2.1.1. Cellulose

12.5.2.1.2. Alginate

12.5.2.1.3. Chitosan

12.5.2.1.4. Others

12.5.2.2. The UK Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

12.5.2.2.1. Drug Delivery

12.5.2.2.2. Research

12.5.2.2.3. Regenerative Medicine

12.5.2.2.4. Cell Transplantation

12.5.2.2.5. Others

12.5.2.3. The UK Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

12.5.2.3.1. Cancer

12.5.2.3.2. Diabetes

12.5.2.3.3. Others

12.5.3. Spain

12.5.3.1. Spain Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

12.5.3.1.1. Cellulose

12.5.3.1.2. Alginate

12.5.3.1.3. Chitosan

12.5.3.1.4. Others

12.5.3.2. Spain Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

12.5.3.2.1. Drug Delivery

12.5.3.2.2. Research

12.5.3.2.3. Regenerative Medicine

12.5.3.2.4. Cell Transplantation

12.5.3.2.5. Others

12.5.3.3. Spain Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

12.5.3.3.1. Cancer

12.5.3.3.2. Diabetes

12.5.3.3.3. Others

12.5.4. Germany

12.5.4.1. Germany Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

12.5.4.1.1. Cellulose

12.5.4.1.2. Alginate

12.5.4.1.3. Chitosan

12.5.4.1.4. Others

12.5.4.2. Germany Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

12.5.4.2.1. Drug Delivery

12.5.4.2.2. Research

12.5.4.2.3. Regenerative Medicine

12.5.4.2.4. Cell Transplantation

12.5.4.2.5. Others

12.5.4.3. Germany Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

12.5.4.3.1. Cancer

12.5.4.3.2. Diabetes

12.5.4.3.3. Others

12.5.5. Italy

12.5.5.1. Italy Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

12.5.5.1.1. Cellulose

12.5.5.1.2. Alginate

12.5.5.1.3. Chitosan

12.5.5.1.4. Others

12.5.5.2. Italy Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

12.5.5.2.1. Drug Delivery

12.5.5.2.2. Research

12.5.5.2.3. Regenerative Medicine

12.5.5.2.4. Cell Transplantation

12.5.5.2.5. Others

12.5.5.3. Italy Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

12.5.5.3.1. Cancer

12.5.5.3.2. Diabetes

12.5.5.3.3. Others

12.5.6. Nordic Countries

12.5.6.1. Nordic Countries Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

12.5.6.1.1. Cellulose

12.5.6.1.2. Alginate

12.5.6.1.3. Chitosan

12.5.6.1.4. Others

12.5.6.2. Nordic Countries Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

12.5.6.2.1. Drug Delivery

12.5.6.2.2. Research

12.5.6.2.3. Regenerative Medicine

12.5.6.2.4. Cell Transplantation

12.5.6.2.5. Others

12.5.6.3. Nordic Countries Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

12.5.6.3.1. Cancer

12.5.6.3.2. Diabetes

12.5.6.3.3. Others

12.5.6.4. Nordic Countries Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Country

12.5.6.4.1. Denmark

12.5.6.4.2. Finland

12.5.6.4.3. Iceland

12.5.6.4.4. Sweden

12.5.6.4.5. Norway

12.5.7. Benelux Union

12.5.7.1. Benelux Union Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

12.5.7.1.1. Cellulose

12.5.7.1.2. Alginate

12.5.7.1.3. Chitosan

12.5.7.1.4. Others

12.5.7.2. Benelux Union Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

12.5.7.2.1. Drug Delivery

12.5.7.2.2. Research

12.5.7.2.3. Regenerative Medicine

12.5.7.2.4. Cell Transplantation

12.5.7.2.5. Others

12.5.7.3. Benelux Union Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

12.5.7.3.1. Cancer

12.5.7.3.2. Diabetes

12.5.7.3.3. Others

12.5.7.4. Benelux Union Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Country

12.5.7.4.1. Belgium

12.5.7.4.2. The Netherlands

12.5.7.4.3. Luxembourg

12.5.8. Rest of Europe

12.5.8.1. Rest of Europe Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

12.5.8.1.1. Cellulose

12.5.8.1.2. Alginate

12.5.8.1.3. Chitosan

12.5.8.1.4. Others

12.5.8.2. Rest of Europe Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

12.5.8.2.1. Drug Delivery

12.5.8.2.2. Research

12.5.8.2.3. Regenerative Medicine

12.5.8.2.4. Cell Transplantation

12.5.8.2.5. Others

12.5.8.3. Rest of Europe Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

12.5.8.3.1. Cancer

12.5.8.3.2. Diabetes

12.5.8.3.3. Others

12.6. Key Segment for Channeling Investments

12.6.1. By Country

12.6.2. By Polymeric Material

12.6.3. By Application

12.6.4. By Disease Indication

13. Asia Pacific Live Cell Encapsulation Market Analysis and Forecasts, 2021 - 2029

13.1. Overview

13.1.1. Asia Pacific Live Cell Encapsulation Market Revenue (US$ Mn)

13.2. Asia Pacific Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

13.2.1. Cellulose

13.2.2. Alginate

13.2.3. Chitosan

13.2.4. Others

13.3. Asia Pacific Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

13.3.1. Drug Delivery

13.3.2. Research

13.3.3. Regenerative Medicine

13.3.4. Cell Transplantation

13.3.5. Others

13.4. Asia Pacific Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

13.4.1. Cancer

13.4.2. Diabetes

13.4.3. Others

13.5. Asia Pacific Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Country

13.5.1. China

13.5.1.1. China Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

13.5.1.1.1. Cellulose

13.5.1.1.2. Alginate

13.5.1.1.3. Chitosan

13.5.1.1.4. Others

13.5.1.2. China Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

13.5.1.2.1. Drug Delivery

13.5.1.2.2. Research

13.5.1.2.3. Regenerative Medicine

13.5.1.2.4. Cell Transplantation

13.5.1.2.5. Others

13.5.1.3. China Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

13.5.1.3.1. Cancer

13.5.1.3.2. Diabetes

13.5.1.3.3. Others

13.5.2. Japan

13.5.2.1. Japan Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

13.5.2.1.1. Cellulose

13.5.2.1.2. Alginate

13.5.2.1.3. Chitosan

13.5.2.1.4. Others

13.5.2.2. Japan Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

13.5.2.2.1. Drug Delivery

13.5.2.2.2. Research

13.5.2.2.3. Regenerative Medicine

13.5.2.2.4. Cell Transplantation

13.5.2.2.5. Others

13.5.2.3. Japan Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

13.5.2.3.1. Cancer

13.5.2.3.2. Diabetes

13.5.2.3.3. Others

13.5.3. India

13.5.3.1. India Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

13.5.3.1.1. Cellulose

13.5.3.1.2. Alginate

13.5.3.1.3. Chitosan

13.5.3.1.4. Others

13.5.3.2. India Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

13.5.3.2.1. Drug Delivery

13.5.3.2.2. Research

13.5.3.2.3. Regenerative Medicine

13.5.3.2.4. Cell Transplantation

13.5.3.2.5. Others

13.5.3.3. India Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

13.5.3.3.1. Cancer

13.5.3.3.2. Diabetes

13.5.3.3.3. Others

13.5.4. New Zealand

13.5.4.1. New Zealand Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

13.5.4.1.1. Cellulose

13.5.4.1.2. Alginate

13.5.4.1.3. Chitosan

13.5.4.1.4. Others

13.5.4.2. New Zealand Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

13.5.4.2.1. Drug Delivery

13.5.4.2.2. Research

13.5.4.2.3. Regenerative Medicine

13.5.4.2.4. Cell Transplantation

13.5.4.2.5. Others

13.5.4.3. New Zealand Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

13.5.4.3.1. Cancer

13.5.4.3.2. Diabetes

13.5.4.3.3. Others

13.5.5. Australia

13.5.5.1. Australia Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

13.5.5.1.1. Cellulose

13.5.5.1.2. Alginate

13.5.5.1.3. Chitosan

13.5.5.1.4. Others

13.5.5.2. Australia Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

13.5.5.2.1. Drug Delivery

13.5.5.2.2. Research

13.5.5.2.3. Regenerative Medicine

13.5.5.2.4. Cell Transplantation

13.5.5.2.5. Others

13.5.5.3. Australia Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

13.5.5.3.1. Cancer

13.5.5.3.2. Diabetes

13.5.5.3.3. Others

13.5.6. South Korea

13.5.6.1. South Korea Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

13.5.6.1.1. Cellulose

13.5.6.1.2. Alginate

13.5.6.1.3. Chitosan

13.5.6.1.4. Others

13.5.6.2. South Korea Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

13.5.6.2.1. Drug Delivery

13.5.6.2.2. Research

13.5.6.2.3. Regenerative Medicine

13.5.6.2.4. Cell Transplantation

13.5.6.2.5. Others

13.5.6.3. South Korea Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

13.5.6.3.1. Cancer

13.5.6.3.2. Diabetes

13.5.6.3.3. Others

13.5.7. Southeast Asia

13.5.7.1. Southeast Asia Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

13.5.7.1.1. Cellulose

13.5.7.1.2. Alginate

13.5.7.1.3. Chitosan

13.5.7.1.4. Others

13.5.7.2. Southeast Asia Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

13.5.7.2.1. Drug Delivery

13.5.7.2.2. Research

13.5.7.2.3. Regenerative Medicine

13.5.7.2.4. Cell Transplantation

13.5.7.2.5. Others

13.5.7.3. Southeast Asia Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

13.5.7.3.1. Cancer

13.5.7.3.2. Diabetes

13.5.7.3.3. Others

13.5.7.4. Southeast Asia Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Country

13.5.7.4.1. Indonesia

13.5.7.4.2. Thailand

13.5.7.4.3. Malaysia

13.5.7.4.4. Singapore

13.5.7.4.5. Rest of Southeast Asia

13.5.8. Rest of Asia Pacific

13.5.8.1. Rest of Asia Pacific Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

13.5.8.1.1. Cellulose

13.5.8.1.2. Alginate

13.5.8.1.3. Chitosan

13.5.8.1.4. Others

13.5.8.2. Rest of Asia Pacific Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

13.5.8.2.1. Drug Delivery

13.5.8.2.2. Research

13.5.8.2.3. Regenerative Medicine

13.5.8.2.4. Cell Transplantation

13.5.8.2.5. Others

13.5.8.3. Rest of Asia Pacific Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

13.5.8.3.1. Cancer

13.5.8.3.2. Diabetes

13.5.8.3.3. Others

13.6. Key Segment for Channeling Investments

13.6.1. By Country

13.6.2. By Polymeric Material

13.6.3. By Application

13.6.4. By Disease Indication

14. Middle East and Africa Live Cell Encapsulation Market Analysis and Forecasts, 2021 - 2029

14.1. Overview

14.1.1. Middle East and Africa Live Cell Encapsulation Market Revenue (US$ Mn)

14.2. Middle East and Africa Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

14.2.1. Cellulose

14.2.2. Alginate

14.2.3. Chitosan

14.2.4. Others

14.3. Middle East and Africa Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

14.3.1. Drug Delivery

14.3.2. Research

14.3.3. Regenerative Medicine

14.3.4. Cell Transplantation

14.3.5. Others

14.4. Middle East and Africa Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

14.4.1. Cancer

14.4.2. Diabetes

14.4.3. Others

14.5. Middle East and Africa Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Country

14.5.1. Saudi Arabia

14.5.1.1. Saudi Arabia Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

14.5.1.1.1. Cellulose

14.5.1.1.2. Alginate

14.5.1.1.3. Chitosan

14.5.1.1.4. Others

14.5.1.2. Saudi Arabia Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

14.5.1.2.1. Drug Delivery

14.5.1.2.2. Research

14.5.1.2.3. Regenerative Medicine

14.5.1.2.4. Cell Transplantation

14.5.1.2.5. Others

14.5.1.3. Saudi Arabia Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

14.5.1.3.1. Cancer

14.5.1.3.2. Diabetes

14.5.1.3.3. Others

14.5.2. UAE

14.5.2.1. UAE Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

14.5.2.1.1. Cellulose

14.5.2.1.2. Alginate

14.5.2.1.3. Chitosan

14.5.2.1.4. Others

14.5.2.2. UAE Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

14.5.2.2.1. Drug Delivery

14.5.2.2.2. Research

14.5.2.2.3. Regenerative Medicine

14.5.2.2.4. Cell Transplantation

14.5.2.2.5. Others

14.5.2.3. UAE Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

14.5.2.3.1. Cancer

14.5.2.3.2. Diabetes

14.5.2.3.3. Others

14.5.3. Egypt

14.5.3.1. Egypt Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

14.5.3.1.1. Cellulose

14.5.3.1.2. Alginate

14.5.3.1.3. Chitosan

14.5.3.1.4. Others

14.5.3.2. Egypt Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

14.5.3.2.1. Drug Delivery

14.5.3.2.2. Research

14.5.3.2.3. Regenerative Medicine

14.5.3.2.4. Cell Transplantation

14.5.3.2.5. Others

14.5.3.3. Egypt Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

14.5.3.3.1. Cancer

14.5.3.3.2. Diabetes

14.5.3.3.3. Others

14.5.4. Kuwait

14.5.4.1. Kuwait Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

14.5.4.1.1. Cellulose

14.5.4.1.2. Alginate

14.5.4.1.3. Chitosan

14.5.4.1.4. Others

14.5.4.2. Kuwait Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

14.5.4.2.1. Drug Delivery

14.5.4.2.2. Research

14.5.4.2.3. Regenerative Medicine

14.5.4.2.4. Cell Transplantation

14.5.4.2.5. Others

14.5.4.3. Kuwait Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

14.5.4.3.1. Cancer

14.5.4.3.2. Diabetes

14.5.4.3.3. Others

14.5.5. South Africa

14.5.5.1. South Africa Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

14.5.5.1.1. Cellulose

14.5.5.1.2. Alginate

14.5.5.1.3. Chitosan

14.5.5.1.4. Others

14.5.5.2. South Africa Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

14.5.5.2.1. Drug Delivery

14.5.5.2.2. Research

14.5.5.2.3. Regenerative Medicine

14.5.5.2.4. Cell Transplantation

14.5.5.2.5. Others

14.5.5.3. South Africa Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

14.5.5.3.1. Cancer

14.5.5.3.2. Diabetes

14.5.5.3.3. Others

14.5.6. Rest of Middle East & Africa

14.5.6.1. Rest of Middle East & Africa Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

14.5.6.1.1. Cellulose

14.5.6.1.2. Alginate

14.5.6.1.3. Chitosan

14.5.6.1.4. Others

14.5.6.2. Rest of Middle East & Africa Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

14.5.6.2.1. Drug Delivery

14.5.6.2.2. Research

14.5.6.2.3. Regenerative Medicine

14.5.6.2.4. Cell Transplantation

14.5.6.2.5. Others

14.5.6.3. Rest of Middle East & Africa Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

14.5.6.3.1. Cancer

14.5.6.3.2. Diabetes

14.5.6.3.3. Others

14.6. Key Segment for Channeling Investments

14.6.1. By Country

14.6.2. By Polymeric Material

14.6.3. By Application

14.6.4. By Disease Indication

15. Latin America Live Cell Encapsulation Market Analysis and Forecasts, 2021 - 2029

15.1. Overview

15.1.1. Latin America Live Cell Encapsulation Market Revenue (US$ Mn)

15.2. Latin America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

15.2.1. Cellulose

15.2.2. Alginate

15.2.3. Chitosan

15.2.4. Others

15.3. Latin America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

15.3.1. Drug Delivery

15.3.2. Research

15.3.3. Regenerative Medicine

15.3.4. Cell Transplantation

15.3.5. Others

15.4. Latin America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

15.4.1. Cancer

15.4.2. Diabetes

15.4.3. Others

15.5. Latin America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Country

15.5.1. Brazil

15.5.1.1. Brazil Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

15.5.1.1.1. Cellulose

15.5.1.1.2. Alginate

15.5.1.1.3. Chitosan

15.5.1.1.4. Others

15.5.1.2. Brazil Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

15.5.1.2.1. Drug Delivery

15.5.1.2.2. Research

15.5.1.2.3. Regenerative Medicine

15.5.1.2.4. Cell Transplantation

15.5.1.2.5. Others

15.5.1.3. Brazil Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

15.5.1.3.1. Cancer

15.5.1.3.2. Diabetes

15.5.1.3.3. Others

15.5.2. Argentina

15.5.2.1. Argentina Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

15.5.2.1.1. Cellulose

15.5.2.1.2. Alginate

15.5.2.1.3. Chitosan

15.5.2.1.4. Others

15.5.2.2. Argentina Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

15.5.2.2.1. Drug Delivery

15.5.2.2.2. Research

15.5.2.2.3. Regenerative Medicine

15.5.2.2.4. Cell Transplantation

15.5.2.2.5. Others

15.5.2.3. Argentina Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

15.5.2.3.1. Cancer

15.5.2.3.2. Diabetes

15.5.2.3.3. Others

15.5.3. Rest of Latin America

15.5.3.1. Rest of Latin America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Polymeric Material

15.5.3.1.1. Cellulose

15.5.3.1.2. Alginate

15.5.3.1.3. Chitosan

15.5.3.1.4. Others

15.5.3.2. Rest of Latin America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Application

15.5.3.2.1. Drug Delivery

15.5.3.2.2. Research

15.5.3.2.3. Regenerative Medicine

15.5.3.2.4. Cell Transplantation

15.5.3.2.5. Others

15.5.3.3. Rest of Latin America Live Cell Encapsulation Market Revenue (US$ Mn) and Forecasts, By Disease Indication

15.5.3.3.1. Cancer

15.5.3.3.2. Diabetes

15.5.3.3.3. Others

15.6. Key Segment for Channeling Investments

15.6.1. By Country

15.6.2. By Polymeric Material

15.6.3. By Application

15.6.4. By Disease Indication

16. Competitive Benchmarking

16.1. Brand Benchmarking

16.2. Market Share Analysis, 2020

16.3. Global Presence and Growth Strategies

16.3.1. Mergers and Acquisitions

16.3.2. Product Launches

16.3.3. Investments Trends

16.3.4. R&D Initiatives

17. Player Profiles

17.1. Austrianova

17.1.1. Company Details

17.1.2. Company Overview

17.1.3. Product Offerings

17.1.4. Key Developments

17.1.5. Financial Analysis

17.1.6. SWOT Analysis

17.1.7. Business Strategies

17.2. Other Market Participants

17.2.1. Company Details

17.2.2. Company Overview

17.2.3. Product Offerings

17.2.4. Key Developments

17.2.5. Financial Analysis

17.2.6. SWOT Analysis

17.2.7. Business Strategies

17.3. Blacktrace Holdings Ltd.

17.3.1. Company Overview

17.3.2. Product Offerings

17.3.3. Key Developments

17.3.4. Financial Analysis

17.3.5. SWOT Analysis

17.3.6. Business Strategies

17.4. Büchi Labortechnik AG

17.4.1. Company Overview

17.4.2. Product Offerings

17.4.3. Key Developments

17.4.4. Financial Analysis

17.4.5. SWOT Analysis

17.4.6. Business Strategies

17.5. Defymed

17.5.1. Company Overview

17.5.2. Product Offerings

17.5.3. Key Developments

17.5.4. Financial Analysis

17.5.5. SWOT Analysis

17.5.6. Business Strategies

17.6. Evonik Industries

17.6.1. Company Overview

17.6.2. Product Offerings

17.6.3. Key Developments

17.6.4. Financial Analysis

17.6.5. SWOT Analysis

17.6.6. Business Strategies

17.7. Gloriana Therapeutics

17.7.1. Company Overview

17.7.2. Product Offerings

17.7.3. Key Developments

17.7.4. Financial Analysis

17.7.5. SWOT Analysis

17.7.6. Business Strategies

17.8. Merck KGaA

17.8.1. Company Overview

17.8.2. Product Offerings

17.8.3. Key Developments

17.8.4. Financial Analysis

17.8.5. SWOT Analysis

17.8.6. Business Strategies

17.9. PharmaCyte Biotech Inc.

17.9.1. Company Overview

17.9.2. Product Offerings

17.9.3. Key Developments

17.9.4. Financial Analysis

17.9.5. SWOT Analysis

17.9.6. Business Strategies

17.10. Sigilon Therapeutics, Inc.

17.10.1. Company Overview

17.10.2. Product Offerings

17.10.3. Key Developments

17.10.4. Financial Analysis

17.10.5. SWOT Analysis

17.10.6. Business Strategies

17.11. Other Market Participants

18. Key Findings

**Exclusive for Multi-User and Enterprise User.

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.

Prominent participants in our primary research process include:

Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources: